Tactile Medical Q2 2025: Strong Growth & Market Expansion

Tactile Medicals Q2 2025 earnings report reveals robust growth, with total revenue surging 7.8% to $78.9 million. Lymphedema products saw a modest 2% increase, while airway clearance products like AffloVest skyrocketed 51.6%. Despite a dip in adjusted EBITDA due to investments in tech and sales teams, the company is optimistic about its 293-rep sales force and plans to reach over 300 by year-end. The lymphedema market, with 145,000 treated patients growing 10% annually, presents a significant opportunity for penetration. Airway clearance products are poised for growth due to bronchiectasis awareness and partnerships with top DMEs. The companys full-year guidance anticipates 6-8% revenue growth, with lymphedema at 1.5-3% and airway at 40-43%. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/f215aeb7d72880b7